Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | No | Yes |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Daewoong Co., Ltd. |
| Boryung Corporation |
| Mezzion Pharma Co.,Ltd. |
| DongKook Pharmaceutical Co., Ltd. |
| Hanall Biopharma Co., Ltd. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| A003090 | A003850 | A140410 | A086450 | A009420 | A185750 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 6% | 10% | -36% | 11% | -1% | 13% | ||
| Fiscal Year - 1 | 17% | 8% | -29% | 9% | 2% | 30% | ||
| Fiscal Year - 2 | 13% | 8% | -82% | 11% | 0% | 14% | ||
| Fiscal Year - 3 | 11% | 11% | -23% | 12% | 5% | 8% | ||
| Fiscal Year - 4 | 15% | 9% | -28% | 14% | 12% | 18% | ||
| Fiscal Year - 5 | 10% | 12% | -47% | 17% | 15% | 12% | ||
| Average | 12% | 10% | -41% | 12% | 6% | 16% | ||
| Median | 12% | 10% | -33% | 11% | 4% | 13% | ||
| Benchmarks | Ticker | |||||||
| Daewoong Co., Ltd. | KOSE:A003090 | |||||||
| Boryung Corporation | KOSE:A003850 | |||||||
| Mezzion Pharma Co.,Ltd. | KOSDAQ:A140410 | |||||||
| DongKook Pharmaceutical Co., Ltd. | KOSDAQ:A086450 | |||||||
| Hanall Biopharma Co., Ltd. | KOSE:A009420 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | A003090 | A003850 | A140410 | A086450 | A009420 | A185750 | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 1,936,917 | 1,017,107 | 8,612 | 812,166 | 138,944 | 1,586,431 | ||
| Fiscal Year | 1,936,917 | 1,017,107 | 8,612 | 812,166 | 138,944 | 1,586,431 | ||
| Fiscal Year - 1 | 1,813,841 | 859,626 | 31,721 | 730,994 | 134,910 | 1,669,404 | ||
| Fiscal Year - 2 | 1,697,338 | 760,476 | 30,726 | 661,647 | 109,995 | 1,488,345 | ||
| Fiscal Year - 3 | 1,511,374 | 627,279 | 26,654 | 594,193 | 101,594 | 1,343,559 | ||
| Fiscal Year - 4 | 1,355,337 | 561,867 | 28,634 | 559,103 | 88,602 | 1,303,006 | ||
| Fiscal Year - 5 | 1,365,679 | 524,269 | 17,920 | 482,280 | 108,452 | 1,079,338 | ||
| Net Income | ||||||||
| Latest Twelve Months | 57,886 | 69,633 | (19,477) | 60,769 | (1,805) | 109,073 | ||
| Fiscal Year | 57,886 | 69,633 | (19,477) | 60,769 | (1,805) | 109,073 | ||
| Fiscal Year - 1 | 152,665 | 40,203 | (12,728) | 46,775 | 3,509 | 212,521 | ||
| Fiscal Year - 2 | 102,566 | 41,894 | (36,298) | 52,896 | 251 | 80,953 | ||
| Fiscal Year - 3 | 78,730 | 43,044 | (13,603) | 50,345 | 8,896 | 42,720 | ||
| Fiscal Year - 4 | 98,379 | 26,856 | (13,873) | 55,925 | 19,765 | 91,633 | ||
| Fiscal Year - 5 | 61,493 | 32,222 | (23,301) | 56,312 | 19,174 | 53,882 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 2,359,277 | 915,512 | 92,149 | 839,535 | 239,747 | 1,402,428 | ||
| Latest Fiscal Quarter | 2,720,694 | 1,164,087 | 73,998 | 953,165 | 212,881 | 1,458,765 | ||
| Fiscal Year | 2,720,694 | 1,164,087 | 73,998 | 953,165 | 212,881 | 1,458,765 | ||
| Fiscal Year - 1 | 2,359,277 | 915,512 | 92,149 | 839,535 | 239,747 | 1,402,428 | ||
| Fiscal Year - 2 | 2,158,905 | 892,386 | 54,022 | 768,330 | 213,451 | 1,124,883 | ||
| Fiscal Year - 3 | 1,929,217 | 828,641 | 83,935 | 750,076 | 198,478 | 1,046,700 | ||
| Fiscal Year - 4 | 1,837,533 | 647,994 | 75,625 | 663,165 | 220,132 | 946,333 | ||
| Fiscal Year - 5 | 1,670,892 | 507,629 | 58,874 | 544,384 | 191,383 | 801,352 | ||
| Fiscal Year - 6 | 1,592,170 | 450,018 | 75,059 | 480,245 | 162,304 | 711,495 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 934,796 | 548,750 | 61,444 | 544,309 | 186,218 | 815,694 | ||
| Latest Fiscal Quarter | 996,507 | 784,503 | 46,063 | 603,092 | 168,351 | 893,969 | ||
| Fiscal Year | 996,507 | 784,503 | 46,063 | 603,092 | 168,351 | 893,969 | ||
| Fiscal Year - 1 | 934,796 | 548,750 | 61,444 | 544,309 | 186,218 | 815,694 | ||
| Fiscal Year - 2 | 828,829 | 515,917 | 26,240 | 501,554 | 168,256 | 622,393 | ||
| Fiscal Year - 3 | 728,685 | 473,863 | 62,793 | 454,181 | 163,492 | 566,010 | ||
| Fiscal Year - 4 | 685,330 | 339,910 | 56,810 | 410,983 | 181,273 | 551,427 | ||
| Fiscal Year - 5 | 617,520 | 282,954 | 42,830 | 362,489 | 140,417 | 473,520 | ||
| Fiscal Year - 6 | 569,628 | 256,103 | 57,319 | 312,638 | 116,918 | 428,725 | ||